GENE ONLINE|News &
EirGenix Showcases End-to-End Biologics Platform at BIO Asia–Taiwan, Highlighting CDMO Growth
2026-07-27
WCC BIOMEDICAL Overcomes Microneedle Array Patches Manufacturing Challenges, Advancing Next-Generation Drug Delivery
2026-07-18
Insilico Medicine and Bora Pharmaceuticals Launch Strategic Alliance to Build a Next-Generation Drug Innovation Model
2026-07-15
BIO Asia Award 2026 Honors Professor Masatoshi Hagiwara and AstraZeneca for Advancing Biotechnology Innovation and Public Health
2026-07-13
AI-designed Drug Rentosertib Advances Into Phase III Trial for Idiopathic Pulmonary Fibrosis
2026-07-08
EirGenix Signs Licensing and Commercialization Agreement with Japanese Pharmaceutical Company for EG1206A in Japan
2026-07-02
Honeybear Biosciences Bringing Total Funds Raised to $34 Million to Accelerate Lead Radiopharmaceutical Candidates into Clinical Trial
2026-06-30
EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026
2026-06-29
Insilico Medicine and SK Biopharmaceuticals Announce Up to $2.5 Billion AI Neuroimmune Drug Collaboration
2026-06-22
Insilico Medicine’s ISM8969 Enters Phase 1 Trial, Advancing Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation and CNS Disorders
2026-06-18
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
